Jacob Lalezari
Vermogen: - $ op 30-06-2026
Vermogen: - $ op 30-06-2026
Dr. Jacob P.
Lalezari, MD, is a Chief Executive Officer at CytoDyn, Inc. Dr. Lalezari was previously employed as a Chief Medical Officer by Virion Therapeutics LLC, a Chief Executive Officer & Medical Director by Quest Clinical Research, Inc., and a Director & Medical Director by Siempre Unidos.
He received his undergraduate degree from the University of Rochester, a graduate degree from the University of Virginia and a doctorate degree from the University of Pennsylvania.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CYTODYN INC. -.--% | 20-03-2026 | 0 ( -.--% ) | - $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| CYTODYN INC. | Algemeen Directeur | 17-11-2023 |
| Bedrijven | Functie | Einde |
|---|---|---|
| CYTODYN INC. | Hoofd Techniek/Wetenschap/O&O | 01-11-2020 |
Siempre Unidos
Siempre Unidos Services to the Health IndustryHealth Services The organization provides government-authorized antiretroviral treatment following Honduran protocols, supported by advanced laboratory monitoring and US HIV specialists for complex cases. The non-profit company is located in the US. It operates HIV and primary care clinics in partnership with the Episcopal Diocese and the Honduran Ministry of Health, serving HIV-positive and HIV-negative individuals, including marginalized populations such as gay men, transgender women, commercial sex workers, Afro-Caribbean (Garifuna) people, prisoners, soldiers, women, and girls living in extreme poverty. Siempre Unidos also advocates for the rights of marginalized workers and sexual minorities, offering pro bono legal representation and monitoring violence and discrimination cases. Siempre Unidos is a nonprofit organization founded in 1999 dedicated to combating the HIV/AIDS epidemic through comprehensive medical treatment, education, and social services. | Hoofd Techniek/Wetenschap/O&O | - |
Virion Therapeutics LLC
Virion Therapeutics LLC BiotechnologyHealth Technology Develops chronic viral disease vaccines | Hoofd Techniek/Wetenschap/O&O | - |
Quest Clinical Research, Inc. | Algemeen Directeur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
CytoDyn, Inc.
CytoDyn, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and commercializes pharmaceutical products to treat human immunodeficiency virus infection | Health Technology |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Siempre Unidos
Siempre Unidos Services to the Health IndustryHealth Services The organization provides government-authorized antiretroviral treatment following Honduran protocols, supported by advanced laboratory monitoring and US HIV specialists for complex cases. The non-profit company is located in the US. It operates HIV and primary care clinics in partnership with the Episcopal Diocese and the Honduran Ministry of Health, serving HIV-positive and HIV-negative individuals, including marginalized populations such as gay men, transgender women, commercial sex workers, Afro-Caribbean (Garifuna) people, prisoners, soldiers, women, and girls living in extreme poverty. Siempre Unidos also advocates for the rights of marginalized workers and sexual minorities, offering pro bono legal representation and monitoring violence and discrimination cases. Siempre Unidos is a nonprofit organization founded in 1999 dedicated to combating the HIV/AIDS epidemic through comprehensive medical treatment, education, and social services. | Health Services |
Virion Therapeutics LLC
Virion Therapeutics LLC BiotechnologyHealth Technology Develops chronic viral disease vaccines | Health Technology |
Quest Clinical Research, Inc. |
Kies jouw editie
Alle financiële informatie op nationaal niveau